Fellowship · Iowa City, IA
Sponsored by University of Iowa Health Care Medical Center
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
The Lancet. Oncology · 2022 · 422 citations · Kimberly Cole
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Nature medicine · 2024 · 238 citations · Gabriel Caponetti
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 90 citations · Alpa Sidhu
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Kidney international · 2024 · 126 citations · Richard J. Smith
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Neurology · 2024 · 113 citations · Katherine Mathews
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study).
Annals of neurology · 2021 · 248 citations ·
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline.
JCO oncology practice · 2026 · 19 citations · James Howe
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe Extension.
Movement disorders : official journal of the Movement Disorder Society · 2023 · 95 citations · Katherine Mathews